Markers of subclinical atherosclerosis in patients with aortic valve sclerosis: A meta-analysis of literature studies

International Journal of Cardiology

Volumn 223, Issue , 2016, Pages 364-370

  Di Minno, Matteo Nicola Dario ^a   Di Minno, Alessandro ^b,c   Songia, Paola ^b,c   Ambrosino, Pasquale ^a   Gripari, Paola ^b   Ravani, Alessio ^b   Pepi, Mauro ^b   Rubba, Paolo Osvaldo ^a   Medda, Emanuela ^d   Tremoli, Elena ^b   Baldassarre, Damiano ^b   Poggio, Paolo ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Aortic valve sclerosis; Arterial stiffness; Carotid plaques; Endothelial function; Intima media thickness; Subclinical atherosclerosis

Indexed keywords

TRIACYLGLYCEROL;

AORTA VALVE DISEASE; AORTIC PULSE WAVE VELOCITY; AORTIC VALVE SCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD VESSEL PARAMETERS; BODY MASS; CAROTID ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATION; HUMAN; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT; SUBCLINICAL ATHEROSCLEROSIS; SYSTEMATIC REVIEW; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CAROTID ARTERY; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE COURSE; META ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM; VASODILATATION;

AORTIC VALVE; AORTIC VALVE STENOSIS; ATHEROSCLEROSIS; CALCINOSIS; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; RISK FACTORS; VASODILATION;

EID: 84982108503     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.08.122     Document Type: Article

References (41)

1. [1] Coffey, S., Cox, B., Williams, M.J., The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 63 (2014), 2852–2861.
2. [2] Gharacholou, S.M., Karon, B.L., Shub, C., Pellikka, P.A., Aortic valve sclerosis and clinical outcomes: moving toward a definition. Am. J. Med. 124 (2011), 103–110.
3. [3] Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P. III, Guyton, R.A., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63 (2014), 2438–2488.
4. [4] Baumgartner, H., Hung, J., Bermejo, J., Chambers, J.B., Evangelista, A., Griffin, B.P., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J. Am. Soc. Echocardiogr. 22 (2009), 1–23 quiz 101-2.
5. [5] Chandra, H.R., Goldstein, J.A., Choudhary, N., O'Neill, C.S., George, P.B., Gangasani, S.R., et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J. Am. Coll. Cardiol. 43 (2004), 169–175.
6. [6] Stewart, B.F., Siscovick, D., Lind, B.K., Gardin, J.M., Gottdiener, J.S., Smith, V.E., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29 (1997), 630–634.
7. [7] Agmon, Y., Khandheria, B.K., Meissner, I., Sicks, J.R., O'Fallon, W.M., Wiebers, D.O., et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J. Am. Coll. Cardiol. 38 (2001), 827–834.
8. [8] Di Minno, M.N., Di Minno, A., Ambrosino, P., Songia, P., Tremoli, E., Poggio, P., Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis. Int J Cardiol. 15:217 (2016 Aug), 1–6.
9. [9] Calabia, J., Torguet, P., Garcia, M., Garcia, I., Martin, N., Guasch, B., et al. Doppler ultrasound in the measurement of pulse wave velocity: agreement with the Complior method. Cardiovasc. Ultrasound, 9, 2011, 13.
10. [10] Matsuzawa, Y., Kwon, T.G., Lennon, R.J., Lerman, L.O., Lerman, A., Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J. Am. Heart Assoc., 4, 2015.
11. [11] Bots, M.L., Grobbee, D.E., Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc. Drugs Ther. 16 (2002), 341–351.
12. [12] de Groot, E., Hovingh, G.K., Wiegman, A., Duriez, P., Smit, A.J., Fruchart, J.C., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109 (2004), III33–III38.
13. [13] Chambless, L.E., Heiss, G., Folsom, A.R., Rosamond, W., Szklo, M., Sharrett, A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am. J. Epidemiol. 146 (1997), 483–494.
14. [14] O'Leary, D.H., Polak, J.F., Kronmal, R.A., Manolio, T.A., Burke, G.L., Wolfson, S.K. Jr., Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340 (1999), 14–22.
15. [15] Belcaro, G., Nicolaides, A.N., Ramaswami, G., Cesarone, M.R., De Sanctis, M., Incandela, L., et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE Study (1)). Atherosclerosis 156 (2001), 379–387.
16. [16] Antonini-Canterin, F., Di Bello, V., Di Salvo, G., La Carrubba, S., Bellieni, G., Benedetto, F., et al. Relation of carotid intima-media thickness and aortic valve sclerosis (from the ISMIR study [“Ispessimento Medio Intimale e Rischio Cardiovascolare”] of the Italian Society of Cardiovascular Echography). Am. J. Cardiol. 103 (2009), 1556–1561.
17. [17] Erdogan, T., Cetin, M., Kocaman, S.A., Durakoglugil, M.E., Ergul, E., Canga, A., Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients. Herz 38 (2013), 915–921.
18. [18] Poggianti, E., Venneri, L., Chubuchny, V., Jambrik, Z., Baroncini, L.A., Picano, E., Aortic valve sclerosis is associated with systemic endothelial dysfunction. J. Am. Coll. Cardiol. 41 (2003), 136–141.
19. [19] Celik, S., Durmus, I., Korkmaz, L., Gedikli, O., Kaplan, S., Orem, C., et al. Aortic pulse wave velocity in subjects with aortic valve sclerosis. Echocardiography 25 (2008), 1112–1116.
20. [20] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 6, 2009, e1000097.
21. [21] Otto, C.M., Lind, B.K., Kitzman, D.W., Gersh, B.J., Siscovick, D.S., Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Engl. J. Med. 341 (1999), 142–147.
22. [22] Juni, P., Witschi, A., Bloch, R., Egger, M., The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282 (1999), 1054–1060.
23. [23] Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
24. [24] Sterne, J.A., Egger, M., Smith, G.D., Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323 (2001), 101–105.
25. [25] Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000), 455–463.
26. [26] Korkmaz, L., Agac, M.T., Ata Korkmaz, A., Erkan, H., Acar, Z., Celik, S., Relationship between aortic valve sclerosis and different vascular damage markers: an observational study. Anadolu Kardiyol. Derg. 13 (2013), 452–456.
27. [27] Sgorbini, L., Scuteri, A., Leggio, M., Gianni, W., Nevola, E., Leggio, F., Carotid intima-media thickness, carotid distensibility and mitral, aortic valve calcification: a useful diagnostic parameter of systemic atherosclerotic disease. J. Cardiovasc. Med. (Hagerstown) 8 (2007), 342–347.
28. [28] Yamaura, Y., Nishida, T., Watanabe, N., Akasaka, T., Yoshida, K., Relation of aortic valve sclerosis to carotid artery intima-media thickening in healthy subjects. Am. J. Cardiol. 94 (2004), 837–839.
29. [29] Rossi, A., Faggiano, P., Amado, A.E., Cicoira, M., Bonapace, S., Franceschini, L., et al. Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. Heart Vessel. 29 (2014), 776–783.
30. [30] Schönenberger, A., Winkelspecht, B., Kohler, H., Girndt, M., High prevalence of aortic valve alterations in haemodialysis patients is associated with signs of chronic inflammation. Nephron Clin. Pract. 96 (2004), c48–c55.
31. [31] Soylu, M., Demir, A.D., Ozdemir, O., Uzun, Y., Korkmaz, S., Relationship between plaque morphology of carotid artery and aortic valve calcification. Angiology 54 (2003), 637–640.
32. [32] Korkmaz, L., Agac, M.T., Bektas, H., Varol, M.O., Erkan, H., Acar, Z., et al. Aortic valve sclerosis is a sign of increased arterial stiffness in clinically asymptomatic subjects. Cardiol. J. 20 (2013), 318–322.
33. [33] Ngo, D.T., Sverdlov, A.L., Willoughby, S.R., Nightingale, A.K., Chirkov, Y.Y., McNeil, J.J., et al. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc. Imaging 2 (2009), 919–927.
34. [34] Nightingale, A.K., Sverdlov, A.L., Rajendran, S., Mishra, K., Heresztyn, T., Ngo, D.T., et al. Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects. Int. J. Cardiol. 150 (2011), 33–38.
35. [35] Baldassarre, D., Veglia, F., Hamsten, A., Humphries, S.E., Rauramaa, R., de Faire, U., et al. Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 2273–2279.
36. [36] Fantin, F., Mattocks, A., Bulpitt, C.J., Banya, W., Rajkumar, C., Is augmentation index a good measure of vascular stiffness in the elderly?. Age Ageing 36 (2007), 43–48.
37. [37] van der Meer, I.M., Bots, M.L., Hofman, A., del Sol, A.I., van der Kuip, D.A., Witteman, J.C., Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 109 (2004), 1089–1094.
38. [38] Cooke, J.P., Tsao, P.S., Is NO an endogenous antiatherogenic molecule?. Arterioscler. Thromb. 14 (1994), 653–655.
39. [39] Green, D.J., Jones, H., Thijssen, D., Cable, N.T., Atkinson, G., Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?. Hypertension 57 (2011), 363–369.
40. [40] Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 192 (2007), 197–203.
41. [41] Vlachopoulos, C., Aznaouridis, K., Stefanadis, C., Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 55 (2010), 1318–1327.